MRManuel Rangel-Grimaldo

Manuel Rangel-Grimaldo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manuel Rangel-Grimaldo has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative Antinociceptive Evaluation of Hofmeisterin I and Analogues from Hofmeisteria schaffneri in Zebrafish and Mice

    by Sebastián Martínez Flores, Gabriela García-Marín, María Guadalupe Martínez-Villarreal, Manuel López-Ortiz, Manuel Eduardo Rangel-Grimaldo, Simón Hernández Ortega, Myrna Déciga-Campos, Rachel Mata

    Hofmeisteria schaffneri (Asteraceae) is a medicinal plant used in Central Mexico for pain relief. Although thymol- and northymol-derived metabolites contribute to its antinociceptive activity, the low abundance of the latter has limited evaluation. An optimized synthetic route to hofmeisterin I (1) improved yields and reduced reaction times, enabling biological assessment. Hofmeisterin I (1) and derivatives were tested in zebrafish (Danio rerio) and murine formalin models. Halogenated derivatives were toxic and minimally active, whereas the acetylated analogue exhibited higher potency but limited safety. A new nitrogen-containing imide analogue, namely, 1-(2-(5-bromo-2-hydroxy-4-methylphenyl)-2-oxoethyl)­pyrrolidine-2,5-dione (12), exhibited improved efficacy and a safer profile. Mechanistic studies indicated the involvement of TRPV1, CB2, and PPARγ receptors, with modulation by the opioid and serotonergic systems. Collectively, these findings highlight compound 12 as a promising antinociceptive scaffold. X-ray analyses of 1 and 12 are also reported.

  • Open Access

    Chemical, Nutritional, and Antihyperglycemic Studies on Sonora Gum

    by Araceli Pérez-Vásquez, Vanya Meneses-Pérez, Valeria Reyes-Pérez, Laura Flores-Bocanegra, Manuel Rangel-Grimaldo, Edelmira Linares, Robert Bye, Rachel Mata

    The Rarámuri Indigenous people of Chihuahua, Mexico, use the gum of Tachardiella fulgens (“arı́” or Sonora gum) as a medicinal agent and food. Thus, this work established the chemical composition, nutritional value, potential toxicity, and antihyperglycemic action of Sonora gum. Using spectroscopic, spectrometric, and chromatographic methods including UHPLC-MS analysis, it was demonstrated that arı́ contains anthraquinones (laccaic acids A, B, and E, xantholaccaic acid B, emodin, and erythrolaccin), farnesol, and nerolidol derivatives including (2Z,6E,10E)-farnesol-12-oic acid (1), a new natural product, crocinervolide, and (6E,10E,3S)-nerolidol-12-oic acid. The volatilome, determined by headspace solid-phase microextraction coupled with GC-MS analysis, was characterized by lilac derivatives, fatty acids, and cedrene alcohols. Using official AOAC and the US Department of Agriculture methods, the proximal analysis revealed that arı́ contains high dietary fiber and vitamins B2 and B3. In addition, an aqueous extract of arı́ significantly reduced the postprandial peak at the highest dose tested (316 mg/kg) in healthy and hyperglycemic mice during an oral glucose tolerance test, meaning that arı́ increases glucose utilization in the hyperglycemic condition. According to the Lorke method, the LD50 of the extract was estimated to be above 5 g/kg, indicating that the extract is practically nontoxic. This work represents the first comprehensive study of the chemical, pharmacological, and nutritional aspects of arı́, a valuable Mexican food. The findings reveal that arı́ is a source of bioactive specialized metabolites, including anthraquinones and sesquiterpenoid acids, lilac aldehydes, fatty acids, and micro- and macronutrients. Thus, the use of arı́ as both food and medicine has a rational basis and enhances knowledge of Mexican ancestral foods and medicine.


  • Open Access

    An integrative genomic and chemical similarity approach linking fungal secondary metabolites and biosynthetic gene clusters

    by Karin Steffen, Manuel Rangel-Grimaldo, Thomas J. C. Sauters, David C. Rinker, Huzefa A. Raja, Tyler N. Graf, Adiyantara Gumilang, Olivia L. Riedling, Gustavo H. Goldman, Nicholas H. Oberlies, et al.

    Fungi are well known to biosynthesize structurally complex secondary metabolites (SMs) with diverse bioactivities. These fungal SMs are frequently produced by biosynthetic gene clusters (BGCs). Linking SMs to their BGCs is key to understanding their chemical and biological functions. Reasoning that structural similarity of SMs arises from similarities in the genes involved in their biosynthesis, we developed an integrative approach that leverages known BGC–SM pairs to predict global links across SMs and BGCs in fungi. As proof of concept, we systematically interrogated metabolomes and genomes of 16 strains of the filamentous fungus Aspergillus fischeri , detecting a total of 60 metabolites. Of those, we were able to assign 22 to known BGC–SM pairs and propose specific hypotheses for the remaining 38 metabolites. These results suggest that coupling genomic similarity and chemical structure-based similarity is a straightforward and high-throughput approach for linking fungal SMs to their BGCs.


  • Open Access

    Biological and mechanical properties of a self-curing acrylic resin enriched with AgNPs as a proposal for orthopedic aparatology

    by Christian Andrea Lopez-Ayuso, Rene Garcia-Contreras, Ravichandran Manisekaran, Mario Figueroa, Manuel Rangel-Grimaldo, Mariano Jacome, Ruben Abraham Dominguez-Perez, Salvador Lopez-Morales, Sol Cristians, Laura Susana Acosta-Torres

    PMMA incorporated with biosynthesized silver nanoparticles using Pelargonium × hortorum exhibit enhanced antimicrobial activity, without affecting its biocompatibility and mechanical properties, offering a proposal for improving orthodontic devices.


  • Open Access

    Bioactivity-driven fungal metabologenomics identifies antiproliferative stemphone analogs and their biosynthetic gene cluster

    by Navid J. Ayon, Cody E. Earp, Raveena Gupta, Fatma A. Butun, Ashley E. Clements, Alexa G. Lee, David Dainko, Matthew T. Robey, Manead Khin, Lina Mardiana, et al.

    Introduction: Fungi biosynthesize chemically diverse secondary metabolites with a wide range of biological activities. Natural product scientists have increasingly turned towards bioinformatics approaches, combining metabolomics and genomics to target secondary metabolites and their biosynthetic machinery. We recently applied an integrated metabologenomics workflow to 110 fungi and identified more than 230 high-confidence linkages between metabolites and their biosynthetic pathways. Objectives: To prioritize the discovery of bioactive natural products and their biosynthetic pathways from these hundreds of high-confidence linkages, we developed a bioactivity-driven metabologenomics workflow combining quantitative chemical information, antiproliferative bioactivity data, and genome sequences. Methods: The 110 fungi from our metabologenomics study were tested against multiple cancer cell lines to identify which strains produced antiproliferative natural products. Three strains were selected for further study, fractionated using flash chromatography, and subjected to an additional round of bioactivity testing and mass spectral analysis. Data were overlaid using biochemometrics analysis to predict active constituents early in the fractionation process following which their biosynthetic pathways were identified using metabologenomics. Results: We isolated three new-to-nature stemphone analogs, 19-acetylstemphones G (1), B (2) and E (3), that demonstrated antiproliferative activity ranging from 3 to 5 µM against human melanoma (MDA-MB-435) and ovarian cancer (OVACR3) cells. We proposed a rational biosynthetic pathway for these compounds, highlighting the potential of using bioactivity as a filter for the analysis of integrated—Omics datasets. Conclusions: This work demonstrates how the incorporation of biochemometrics as a third dimension into the metabologenomics workflow can identify bioactive metabolites and link them to their biosynthetic machinery.


  • Polychlorinated cyclopentenes from a marine derived Periconia sp. (strain G1144)

    by Kristóf B. Cank, Robert A. Shepherd, Sonja L. Knowles, Manuel Rangel-Grimaldo, Huzefa A. Raja, Zoie L. Bunch, Nadja B. Cech, Christopher A. Rice, Dennis E. Kyle, Joseph O. Falkinham, et al.


  • Protein tyrosine phosphatase 1B inhibitors from the fungus Malbranchea albolutea

    by Miriam Díaz-Rojas, Huzefa Raja, Martin González-Andrade, José Rivera-Chávez, Manuel Rangel-Grimaldo, Isabel Rivero-Cruz, Rachel Mata


  • Pharmacological Analysis of the Anti-inflammatory and Antiallodynic Effects of Zinagrandinolide E from Zinnia grandiflora in Mice

    by Valeria Itzel Reyes-Pérez, Vinicio Granados-Soto, Manuel Rangel-Grimaldo, Myrna Déciga-Campos, Rachel Mata

    Zinagrandinolide E (1, ZGE) is an elemanolide with antinociceptive action isolated from Zinnia grandiflora (Asteraceae), valued in North México and southwestern United States for pain relief. Herein, we report the anti-inflammatory and antiallodynic action of ZGE (1) in carrageenan-induced inflammation and tactile allodynia in mice and in a neuropathic pain model in hyperglycemic mice. Local peripheral administration of ZGE (1–30 μg/paw) induced dose-dependent acute anti-inflammatory and antiallodynic effects. The anti-inflammatory effect was comparable to diclofenac (30 μg/paw). Intrathecal (i.t.) administration of ZGE (30 μg) in acute experiments did not affect carrageenan-induced inflammation but significantly reduced tactile allodynia in a dose-dependent fashion. In long-term experiments (15 or 6 days), using two different scheme treatments (pretreatment or post-treatment), ZGE (3–30 μg/paw) showed antiallodynic but not anti-inflammatory action. Local peripheral (3–30 μg/paw) or intrathecal (3–30 μg) administration of ZGE partially reversed tactile allodynia in hyperglycemic mice, better or comparable, respectively, with those of pregabalin (30 μg/paw or 30 μg i.t.). The effects were dose-dependent. According to the pharmacological tools employed, the anti-inflammatory and antiallodynic activities of ZGE are multitarget; these involve the opioidergic, serotoninergic, and GABAergic systems, as well as the NO-cGMP-ATP-sensitive K+ channel signaling pathway.


  • Open Access

    Flavonoids and Terpenoids with PTP-1B Inhibitory Properties from the Infusion of Salvia amarissima Ortega

    by Eric Salinas-Arellano, Araceli Pérez-Vásquez, Isabel Rivero-Cruz, Rafael Torres-Colin, Martín González-Andrade, Manuel Rangel-Grimaldo, Rachel Mata

    An infusion prepared from the aerial parts of Salvia amarissima Ortega inhibited the enzyme protein tyrosine phosphatase 1B (PTP-1B) (IC50~88 and 33 μg/mL, respectively). Phytochemical analysis of the infusion yielded amarisolide (1), 5,6,4′-trihydroxy-7,3′-dimethoxyflavone (2), 6-hydroxyluteolin (3), rutin (4), rosmarinic acid (5), isoquercitrin (6), pedalitin (7) and a new neo-clerodane type diterpenoid glucoside, named amarisolide G (8a,b). Compound 8a,b is a new natural product, and 2–6 are reported for the first time for the species. All compounds were tested for their inhibitory activity against PTP-1B; their IC50 values ranged from 62.0 to 514.2 μM. The activity was compared to that of ursolic acid (IC50 = 29.14 μM). The most active compound was pedalitin (7). Docking analysis predicted that compound 7 has higher affinity for the allosteric site of the enzyme. Gas chromatography coupled to mass spectrometry analyses of the essential oils prepared from dried and fresh materials revealed that germacrene D (15) and β-selinene (16), followed by β-caryophyllene (13) and spathulenol (17) were their major components. An ultra-high performance liquid chromatography coupled to mass spectrometry method was developed and validated to quantify amarisolide (1) in the ethyl acetate soluble fraction of the infusion of S. amarissima.


  • α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors from Malbranchea circinata

    by Manuel Rangel-Grimaldo, Martha L. Macías-Rubalcava, Martin González-Andrade, Huzefa Raja, Mario Figueroa, Rachel Mata

    During a search for new α-glucosidase and protein tyrosine phosphatase 1B inhibitors from fungal sources, eight new secondary metabolites, including two anthranilic acid-derived peptides (1 and 2), four glycosylated anthraquinones (3–6), 4-isoprenylravenelin (7), and a dimer of 5,8-dihydroxy-4-methoxy-α-tetralone (8), along with four known compounds (9–12), were isolated from solid rice-based cultures of Malbranchea circinata. The structural elucidation of these metabolites was performed using 1D and 2D NMR techniques and DFT-calculated chemical shifts. Compounds 1–3, 9, and 10 showed inhibitory activity to yeast α-glucosidase (αGHY), with IC50 values ranging from 57.4 to 261.3 μM (IC50 acarbose = 585.8 μM). The effect of 10 (10.0 mg/kg) was corroborated in vivo using a sucrose tolerance test in normoglucemic mice. The most active compounds against PTP-1B were 8–10, with IC50 values from 10.9 to 15.3 μM (IC50 ursolic acid = 27.8 μM). Docking analysis of the active compounds into the crystal structures of αGHY and PTP-1B predicted that all compounds bind to the catalytic domains of the enzymes. Together, these results showed that M. circinata is a potential source of antidiabetic drug leads.